A Cost-Effectiveness Tool for Informing Policies on Zika Control

Country or region
Risk period during pregnancy (RPDP) (days) days
Microcephaly probability given mothers with Zika for RPDP (percentage) %
Cost per case of microcephaly (US dollars) USD
Guillain-Barré Syndrome probability given Zika infection (percentage) %
Cost per case of Guillain-Barré Syndrome (US dollars) USD
Zika infections averted directly in pregnant women (percentage of total Zika infections averted) %
Maximum cost of implementation to display (percentage of GDP) %
Maximum Zika infections averted to display (percentage of population) %